The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction

Background/Aims It is unknown whether different β-blockers (BBs) have variable effects on long-term survival of patients with heart failure with reduced ejection fraction (HFrEF). This study compares the effects of two BBs, carvedilol and bisoprolol, on survival in patients with HFrEF. Methods The K...

Full description

Bibliographic Details
Main Authors: Ki Hong Choi, Ga Yeon Lee, Jin-Oh Choi, Eun-Seok Jeon, Hae-Young Lee, Sang Eun Lee, Jae-Joong Kim, Shung Chull Chae, Sang Hong Baek, Seok-Min Kang, Dong-Ju Choi, Byung-Su Yoo, Kye Hun Kim, Myeong-Chan Cho, Hyun-Young Park, Byung-Hee Oh
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2019-09-01
Series:The Korean Journal of Internal Medicine
Subjects:
beta-blocker
heart failure with reduced ejection fraction
carvedilol
bisoprolol
Online Access:http://www.kjim.org/upload/pdf/kjim-2018-009.pdf

Internet

http://www.kjim.org/upload/pdf/kjim-2018-009.pdf

Similar Items